Published in Pharma Investments, Ventures and Law Weekly, November 5th, 2006
The National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) awarded this grant titled "Development and cGMP Manufacture of a Vitrified Typhoid Vaccine," which provides approximately $750,000 in funding to Avant.
"We are very pleased to receive this new SBIR grant and the NIAID's commitment to further development and cGMP manufacture of Ty800 with bulk drying processes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly